Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor site version update.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision footer was updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than any change to the specific trial record.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Revision: v3.5.0 to the version history and removed Revision: v3.4.3.SummaryDifference0.0%

- Check78 days agoChange DetectedA new revision entry v3.4.3 was added to the Record History, and the previous v3.4.2 entry was removed.SummaryDifference0.0%

- Check107 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous entry v3.4.1 was removed.SummaryDifference0.0%

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.